BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 29204144)

  • 1. All-
    Vellozo NS; Pereira-Marques ST; Cabral-Piccin MP; Filardy AA; Ribeiro-Gomes FL; Rigoni TS; DosReis GA; Lopes MF
    Front Immunol; 2017; 8():1560. PubMed ID: 29204144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANK Ligand Helps Immunity to
    Rigoni TS; Vellozo NS; Cabral-Piccin M; Fabiano-Coelho L; Lopes UG; Filardy AA; DosReis GA; Lopes MF
    Front Immunol; 2020; 11():886. PubMed ID: 32477357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.
    Vellozo NS; Rigoni TS; Lopes MF
    Front Immunol; 2021; 12():704429. PubMed ID: 34249011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells alter macrophage immune responses to Leishmania major infection in both susceptible and resistance mice.
    Dameshghi S; Zavaran-Hosseini A; Soudi S; Shirazi FJ; Nojehdehi S; Hashemi SM
    Immunol Lett; 2016 Feb; 170():15-26. PubMed ID: 26703818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
    Scott P; Sacks D; Sher A
    J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity.
    Teixeira MV; Soares SAE; Souza VA; de Souza Marques AM; de Almeida Soares CM; Baeza LC; de Oliveira MAP
    Parasitol Res; 2022 Oct; 121(10):2891-2899. PubMed ID: 35939146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of
    Sandoval Pacheco CM; Araujo Flores GV; Gonzalez K; de Castro Gomes CM; Passero LFD; Tomokane TY; Sosa-Ochoa W; Zúniga C; Calzada J; Saldaña A; Corbett CEP; Silveira FT; Laurenti MD
    J Immunol Res; 2021; 2021():5596876. PubMed ID: 33937417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance Against
    Lopes ME; Dos Santos LM; Sacks D; Vieira LQ; Carneiro MB
    Front Immunol; 2021; 12():730437. PubMed ID: 34745100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection.
    Novais FO; Santiago RC; Báfica A; Khouri R; Afonso L; Borges VM; Brodskyn C; Barral-Netto M; Barral A; de Oliveira CI
    J Immunol; 2009 Dec; 183(12):8088-98. PubMed ID: 19923470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of murine alternatively activated macrophages.
    Weisser SB; McLarren KW; Kuroda E; Sly LM
    Methods Mol Biol; 2013; 946():225-39. PubMed ID: 23179835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.
    Rocha FJ; Schleicher U; Mattner J; Alber G; Bogdan C
    Infect Immun; 2007 Aug; 75(8):3823-32. PubMed ID: 17517868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant host defense against Leishmania major in the absence of SLPI.
    McCartney-Francis N; Jin W; Belkaid Y; McGrady G; Wahl SM
    J Leukoc Biol; 2014 Nov; 96(5):917-29. PubMed ID: 25030421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR2 signaling contributes to the differentiation of protective inflammatory dendritic cells in Leishmania braziliensis infection.
    Costa DL; Lima-Júnior DS; Nascimento MS; Sacramento LA; Almeida RP; Carregaro V; Silva JS
    J Leukoc Biol; 2016 Aug; 100(2):423-32. PubMed ID: 26884611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL/6 and BALB/c mice.
    Schmid M; Zimara N; Wege AK; Ritter U
    Eur J Immunol; 2014 Nov; 44(11):3295-306. PubMed ID: 25142017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Macrophage Activation Markers in an Experimental Model of Cutaneous Leishmaniasis Treated with Photodynamic Therapy Mediated by 5-Aminolevulinic Acid.
    Silva MLF; Alves PM; Souza DM; Silva MV; Dos Santos JP; Paulino TP; Rodrigues DB; Rodrigues V
    Photobiomodul Photomed Laser Surg; 2019 May; 37(5):298-304. PubMed ID: 31084559
    [No Abstract]   [Full Text] [Related]  

  • 17. Boosting immunity to treat parasitic infections: Asaia bacteria expressing a protein from Wolbachia determine M1 macrophage activation and killing of Leishmania protozoans.
    Varotto-Boccazzi I; Epis S; Arnoldi I; Corbett Y; Gabrieli P; Paroni M; Nodari R; Basilico N; Sacchi L; Gramiccia M; Gradoni L; Tranquillo V; Bandi C
    Pharmacol Res; 2020 Nov; 161():105288. PubMed ID: 33160070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spectrum in the susceptibility of leishmanial strains to intracellular killing by murine macrophages.
    Scott P; Sher A
    J Immunol; 1986 Feb; 136(4):1461-6. PubMed ID: 3511147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
    Shankar AH; Morin P; Titus RG
    Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
    von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
    J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.